NSABPB51/RTOG 1304
NRG Oncology/NSABP B-51/RTOG 1304: Phase III Trial Evaluating Benefit of Adjuvant Regional Nodal Irradiation in Patients With Early Breast Cancer Converting to Axillary Lymph Node Negativity After Neoadjuvant Chemotherapy

Released: December 08, 2023

Activity

Progress
1
Course Completed